Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron

29Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Mair, M. J., Mitterer, M., Gattinger, P., Berger, J. M., Trutschnig, W., Bathke, A. C., … Preusser, M. (2022, May 9). Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron. Cancer Cell. Cell Press. https://doi.org/10.1016/j.ccell.2022.04.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free